High-throughput approaches to the quantitative analysis of ketoconazole, a potent inhibitor of cytochrome P450 3A4, in human plasma.

作者: L. Ramos , N. Brignol , R. Bakhtiar , T. Ray , L. M. Mc Mahon

DOI: 10.1002/1097-0231(20001215)14:23<2282::AID-RCM164>3.0.CO;2-V

关键词: CYP3A4Magic bulletAtmospheric-pressure chemical ionizationChemistryAcetonitrileKetoconazoleHuman plasmaQuantitative analysis (chemistry)ChromatographyPharmacologySample preparation

摘要: Ketoconazole, an imidazole-piperazine compound, is orally active antimycotic agent. In addition, ketoconazole a specific inhibitor of cytochrome P450 3A4. As about 60% oxidized drugs are biotransformed by this isoform, the potential effect concomitant administration on drug disposition may be interest during development. The present paper describes three different approaches (methods A, B, and C) to attain high-throughput sample preparation analysis in quantification human plasma. Method A consisted acetonitrile precipitation 96-well plate, transfer supernatant via Tomtec Quadra 96 Model 320, subsequent injection onto 50 x 4.6 mm (i.d.) Develosil Combi-RP-5 column (packed with C30 bonded silica particles). B identical method exception that Michrom Magic Bullet(trade mark) column, 2.0 --> 0.50 (i.d., tapered bore) x25 length, was used. Lastly, C, turbulent-flow chromatography (TurboFlow LC/APCI-MS/MS) module used for direct Sciex API 3000 methods while Micromass Quattro LC employed C. Based values obtained calibrator (standard) quality control samples, all protocols yielded satisfactory accuracy, precision, reduced manual time.

参考文章(50)
Cristobal L. Miranda, Rosita J. Rodriguez, Isoform specificity of N-deacetyl ketoconazole by human and rabbit flavin-containing monooxygenases. Drug Metabolism and Disposition. ,vol. 28, pp. 1083- 1086 ,(2000)
Elizabeth Landrum Michalets, Update: Clinically Significant Cytochrome P‐450 Drug Interactions Pharmacotherapy. ,vol. 18, pp. 84- 112 ,(1998) , 10.1002/J.1875-9114.1998.TB03830.X
Thomas H Eichhold, Debbie L Kuhlenbeck, Timothy R Baker, Mark E Stella, Jack S Amburgey, Mitchell A deLong, James R Hartke, Charles A Cruze, Sherie A Pierce, Kenneth R Wehmeyer, Use of short high-performance liquid chromatography columns and tandem-mass spectrometry for the rapid analysis of a prostaglandin analog, fluprostenol, in rat plasma. Journal of Chromatography B: Biomedical Sciences and Applications. ,vol. 741, pp. 213- 220 ,(2000) , 10.1016/S0378-4347(00)00093-1
Mohammed Jemal, High-throughput quantitative bioanalysis by LC/MS/MS. Biomedical Chromatography. ,vol. 14, pp. 422- 429 ,(2000) , 10.1002/1099-0801(200010)14:6<422::AID-BMC25>3.0.CO;2-I
J. Heeres, L. J. J. Backx, J. H. Mostmans, J. Van Cutsem, Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent. Journal of Medicinal Chemistry. ,vol. 22, pp. 1003- 1005 ,(1979) , 10.1021/JM00194A023
Jerry Zweigenbaum, Katja Heinig, Simon Steinborner, Timothy Wachs, Jack Henion, High-throughput bioanalytical LC/MS/MS determination of benzodiazepines in human urine: 1000 samples per 12 hours. Analytical Chemistry. ,vol. 71, pp. 2294- 2300 ,(1999) , 10.1021/AC9813540
J. Ayrton, G. J. Dear, W. J. Leavens, D. N. Mallett, R. S. Plumb, The use of turbulent flow chromatography/mass spectrometry for the rapid, direct analysis of a novel pharmaceutical compound in plasma Rapid Communications in Mass Spectrometry. ,vol. 11, pp. 1953- 1958 ,(1997) , 10.1002/(SICI)1097-0231(199712)11:18<1953::AID-RCM102>3.0.CO;2-Z